Ropes & Gray LLP > Shanghai, China > Firm Profile

Ropes & Gray LLP > The Legal 500 Rankings

China > Life sciences and healthcare: foreign firms Tier 2

Ropes & Gray LLP routinely acts for global biopharmaceutical and medical device companies, as well as a large proportion of private equity investors. The practice houses experts in licensing, IP, disputes, China regulatory issues, M&A, and capital markets, as well as venture capital investments, equity financings, securities and public company matters. Other notable areas are human genetic regulation, data privacy and research compliance. Dividing his time between Shanghai and New York, Arthur Mok acts for biotechs, multinational pharmaceutical companies and investment sponsors on Greater China matters; and the track record of Eric Wu, who works across the firm’s Hong Kong and Shanghai offices, includes advising biotechnology, pharmaceutical, medical device and consumer healthcare companies, as well as venture capital, private equity and hedge funds.

China > Investment funds: foreign firms Tier 3

Mandated by mega-value fund clients and large sovereign wealth funds, Ropes & Gray LLP has ‘a strong international practice as well as expertise in private equity fund investments’. The team advises on anchor commitments to funds and seeding programmes, along with billion-dollar separate account formations, special focus vehicles, direct investments, co-investments, and secondary transactions. In Hong Kong, Vincent Ip acts for investment advisers and fund sponsors on the formation (and ongoing operation) of China and Asia-focused private investment funds and institutions.

China > Private equity: foreign firms Tier 3

Leveraging enviable cross-office and cross-practice expertise, Ropes & Gray LLP's China private equity team is repeatedly mandated for high-stakes matters by global private equity clients and regional investors. The transactions handled span various sectors, including life sciences, health care, technology, consumer goods, financial services and real estate. Heading up the China private equity team from Hong Kong, Oliver Nip advises global and regional private equity sponsors (and other asset managers) on cross-border buyouts, minority investments, joint ventures, and co-investments.

China > Regulatory/compliance: foreign firms Tier 4

With sector expertise in technology, healthcare, life sciences, real estate, retail and private equity, Ropes & Gray LLP routinely handles high volumes of government and internal investigations involving major corporations and investors. Working between Hong Kong and Singapore, Andrew Dale acts for US and global corporations in corporate investigations; and dividing his time between Boston and Hong Kong, Geoffrey Atkins is an expert in civil and criminal anti-corruption and securities enforcement.

China > Banking and finance: foreign firms Tier 5